Assessment of epicutaneous testing of a monovalent Influenza A (H1N1) 2009 vaccine in egg allergic patients

BACKGROUND: H1N1 is responsible for the first influenza pandemic in 41 years. In the fall of 2009, an H1N1 vaccine became available in Canada with the hopes of reducing the overall effect of the pandemic. The purpose of this study was to assess the safety of administering 2 different doses of a mono...

Descripción completa

Detalles Bibliográficos
Autores principales: Pitt, Tracy, Kalicinsky, Chrystyna, Warrington, Richard, Cisneros, Nestor
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045365/
https://www.ncbi.nlm.nih.gov/pubmed/21314925
http://dx.doi.org/10.1186/1710-1492-7-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045365/
https://www.ncbi.nlm.nih.gov/pubmed/21314925
http://dx.doi.org/10.1186/1710-1492-7-3

Ejemplares similares